Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension
Cardiovasc Drugs Ther
.
2023 Jan 20.
doi: 10.1007/s10557-023-07431-6.
Online ahead of print.
Authors
Justin K Lui
1
2
,
Ruchika A Sangani
3
4
,
Kari R Gillmeyer
3
4
,
Jasmine Vakhshoorzadeh
4
,
Marcin A Trojanowski
4
5
,
Andreea M Bujor
4
5
,
Deepa M Gopal
4
6
,
Renda Soylemez Wiener
3
4
7
,
Michael P LaValley
5
8
,
Elizabeth S Klings
3
4
Affiliations
1
The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. justin.lui@bmc.org.
2
Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. justin.lui@bmc.org.
3
The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
4
Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
5
Section of Rheumatology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
6
Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
7
Center for Healthcare Organization & Implementation Research, VA Boston Healthcare System, Boston, MA, USA.
8
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
PMID:
36662449
DOI:
10.1007/s10557-023-07431-6
No abstract available
Publication types
Published Erratum
Grants and funding
P60 AR047785/AR/NIAMS NIH HHS/United States